Antiepileptic Effect of 2deoxyglucose by Activation of MiR194/K Signaling Pathway

Overview

Journal Zhong Nan Da Xue Xue Bao Yi Xue Ban

Specialty General Medicine

Date 2022 Sep 13

PMID 36097778

Authors

Heng Yang

Chen Zhang

Affiliations

Soon will be listed here.

Abstract

Objectives: Epilepsy is a syndrome of central nervous system dysfunction caused by many reasons, which is mainly characterized by abnormal discharge of neurons in the brain. Therefore, finding new targets for epilepsy therapy has always been the focus and hotspot in neurological research field. Studies have found that 2-deoxy--glucose (2-DG) exerts anti-epileptic effect by up-regulation of K channel subunit mRNA and protein. By using the database of TargetScan and miRBase to perform complementary pairing analysis on the sequences of miRNA and related target genes, it predicted that miR-194 might be the upstream signaling molecule of K channel. This study aims to explore the mechanism by which 2-DG exerts its anti-epileptic effect by regulating K channel subunits and via miR-194.

Methods: A magnesium-free epilepsy model was established and randomly divided into a control group, an epilepsy group (EP group), an EP+2-DG group, and miR-194 groups (including EP+miR-194 mimic, EP+miR-194 mimic+2-DG, EP+miR-194 mimic control, EP+miR-194 inhibitor, EP+miR-194 inhibitor+2-DG, and EP+miR-194 inhibitor control groups). The 2-DG was used to intervene miR-194 mimics, patch-clamp method was used to detect the spontaneous recurrent epileptiform discharges, real-time PCR was used to detect neuronal , and expressions, and the protein levels of Kir6.1 and Kir6.2were detected by Western blotting.

Results: Compared with the control group, there was no significant difference in the amplitude of spontaneous discharge potential in the EP group (>0.05), but the frequency of spontaneous discharge was increased (<0.05). Compared with the EP group, the frequency of spontaneous discharge was decreased (<0.05). Compared with the EP+miR-194 mimic control group, the mRNA and protein expressions of and in the EP+miR-194 mimic group were down-regulated (all <0.05). Compared with the EP+miR-194 inhibitor control group, the mRNA and protein expressions of and in the EP+miR-194 inhibitor group were up-regulated (all <0.05). After pretreatment with miR-194 mimics, the mRNA and protein expression levels of K channel subunits and were decreased (all <0.05). Compared with the EP+2-DG group, the mRNA and protein expression levels of and in the EP+miR-194 mimic+2-DG group were down-regulated (all <0.05) and the mRNA and protein expression levels of and in the EP+miR-194 inhibitor+2-DG group were up-regulated (all <0.05).

Conclusions: The 2-DG might play an anti-epilepsy effect by up-regulating K channel subunits Kir6.1 and Kir6.2via miR-194.

Citing Articles

Upregulation of miR-194-5p or silencing of PRC1 enhances radiotherapy sensitivity in esophageal squamous carcinoma cells.

Wang Y, Yao N, Sun J Heliyon. 2023; 9(12):e22282.

PMID: 38046164 PMC: 10686870. DOI: 10.1016/j.heliyon.2023.e22282.

References

Rubio C, Luna R, Rosiles A, Rubio-Osornio M . Caloric Restriction and Ketogenic Diet Therapy for Epilepsy: A Molecular Approach Involving Pathway and K Channels. Front Neurol. 2020; 11:584298. PMC: 7676225. DOI: 10.3389/fneur.2020.584298. View

Budakoti M, Panwar A, Molpa D, Singh R, Busselberg D, Mishra A . Micro-RNA: The darkhorse of cancer. Cell Signal. 2021; 83:109995. DOI: 10.1016/j.cellsig.2021.109995. View

Long Y, Zhuang K, Ji Z, Han Y, Fei Y, Zheng W . 2-Deoxy-D-Glucose Exhibits Anti-seizure Effects by Mediating the Netrin-G1-KATP Signaling Pathway in Epilepsy. Neurochem Res. 2019; 44(4):994-1004. DOI: 10.1007/s11064-019-02734-3. View

Raoof R, Jimenez-Mateos E, Bauer S, Tackenberg B, Rosenow F, Lang J . Cerebrospinal fluid microRNAs are potential biomarkers of temporal lobe epilepsy and status epilepticus. Sci Rep. 2017; 7(1):3328. PMC: 5468228. DOI: 10.1038/s41598-017-02969-6. View

Ambros V, Ruvkun G . Recent Molecular Genetic Explorations of MicroRNAs. Genetics. 2018; 209(3):651-673. PMC: 6028246. DOI: 10.1534/genetics.118.300291. View

Pansani A, Ghazale P, Dos Santos E, Dos Santos Borges K, Gomes K, Lacerda I . The number and periodicity of seizures induce cardiac remodeling and changes in micro-RNA expression in rats submitted to electric amygdala kindling model of epilepsy. Epilepsy Behav. 2021; 116:107784. DOI: 10.1016/j.yebeh.2021.107784. View

Liu H, Tufa U, Zahra A, Chow J, Sivanenthiran N, Cheng C . Electrographic Features of Spontaneous Recurrent Seizures in a Mouse Model of Extended Hippocampal Kindling. Cereb Cortex Commun. 2021; 2(1):tgab004. PMC: 8152854. DOI: 10.1093/texcom/tgab004. View

Nedergaard S, Andreasen M . Opposing effects of 2-deoxy-d-glucose on interictal- and ictal-like activity when K currents and GABA receptors are blocked in rat hippocampus in vitro. J Neurophysiol. 2018; 119(5):1912-1923. DOI: 10.1152/jn.00732.2017. View

Wang Y, Hussein A, Somasundaram L, Sankar R, Detraux D, Mathieu J . microRNAs Regulating Human and Mouse Naïve Pluripotency. Int J Mol Sci. 2019; 20(23). PMC: 6929104. DOI: 10.3390/ijms20235864. View

10.

Ghasemi M, Shafaroodi H, Karimollah A, Gholipour T, Nezami B, Ebrahimi F . ATP-sensitive potassium channels contribute to the time-dependent alteration in the pentylenetetrazole-induced seizure threshold in diabetic mice. Seizure. 2009; 19(1):53-8. DOI: 10.1016/j.seizure.2009.11.003. View

11.

Yellen G . Ketone bodies, glycolysis, and KATP channels in the mechanism of the ketogenic diet. Epilepsia. 2008; 49 Suppl 8:80-2. PMC: 2646251. DOI: 10.1111/j.1528-1167.2008.01843.x. View

12.

Manford M . Recent advances in epilepsy. J Neurol. 2017; 264(8):1811-1824. PMC: 5533817. DOI: 10.1007/s00415-017-8394-2. View

13.

Brennan G, Henshall D . microRNAs in the pathophysiology of epilepsy. Neurosci Lett. 2017; 667:47-52. DOI: 10.1016/j.neulet.2017.01.017. View

14.

Margaritis K, Margioula-Siarkou G, Giza S, Kotanidou E, Tsinopoulou V, Christoforidis A . Micro-RNA Implications in Type-1 Diabetes Mellitus: A Review of Literature. Int J Mol Sci. 2021; 22(22). PMC: 8621893. DOI: 10.3390/ijms222212165. View

15.

Tran S, Mathon B, Morcos-Sauvain E, Lerond J, Navarro V, Bielle F . [Neuropathology of epilepsy]. Ann Pathol. 2020; 40(6):447-460. DOI: 10.1016/j.annpat.2020.08.001. View

16.

Yang H, Guo R, Wu J, Peng Y, Xie D, Zheng W . The antiepileptic effect of the glycolytic inhibitor 2-deoxy-D-glucose is mediated by upregulation of K(ATP) channel subunits Kir6.1 and Kir6.2. Neurochem Res. 2013; 38(4):677-85. DOI: 10.1007/s11064-012-0958-z. View

17.

Bertran F . [Epilepsy today]. Rev Infirm. 2018; 67(243):14-16. DOI: 10.1016/j.revinf.2018.07.003. View

18.

Liu X, Feng Z, Du L, Huang Y, Ge J, Deng Y . The Potential Role of MicroRNA-124 in Cerebral Ischemia Injury. Int J Mol Sci. 2019; 21(1). PMC: 6981583. DOI: 10.3390/ijms21010120. View

19.

Silverman R . Design and Mechanism of GABA Aminotransferase Inactivators. Treatments for Epilepsies and Addictions. Chem Rev. 2018; 118(7):4037-4070. PMC: 8459698. DOI: 10.1021/acs.chemrev.8b00009. View

20.

Wang X, Luo Y, Liu S, Tan L, Wang S, Man R . MicroRNA-134 plasma levels before and after treatment with valproic acid for epilepsy patients. Oncotarget. 2017; 8(42):72748-72754. PMC: 5641166. DOI: 10.18632/oncotarget.20292. View